170 related articles for article (PubMed ID: 38424578)
1. Development of finely tuned liposome nanoplatform for macrophage depletion.
Choi TH; Yoo RJ; Park JY; Kim JY; Ann YC; Park J; Kim JS; Kim K; Shin YJ; Lee YJ; Lee KC; Park J; Chung H; Seok SH; Im HJ; Lee YS
J Nanobiotechnology; 2024 Feb; 22(1):83. PubMed ID: 38424578
[TBL] [Abstract][Full Text] [Related]
2. Liposomes for targeting of antigens and drugs: immunoadjuvant activity and liposome-mediated depletion of macrophages.
van Rooijen N
J Drug Target; 2008 Aug; 16(7):529-34. PubMed ID: 18686122
[TBL] [Abstract][Full Text] [Related]
3. Macrophage depletion using clodronate liposomes reveals latent dysfunction of the hematopoietic microenvironment associated with persistently imbalanced M1/M2 macrophage polarization in a mouse model of hemophagocytic lymphohistiocytosis.
Koike T; Miura K; Hatta Y; Nakamura H; Hirabayashi Y; Yuda M; Harada T; Hirai S; Tsuboi I; Aizawa S
Ann Hematol; 2023 Dec; 102(12):3311-3323. PubMed ID: 37656190
[TBL] [Abstract][Full Text] [Related]
4. Macrophage depletion diminishes implant-wear-induced inflammatory osteolysis in a mouse model.
Ren W; Markel DC; Schwendener R; Ding Y; Wu B; Wooley PH
J Biomed Mater Res A; 2008 Jun; 85(4):1043-51. PubMed ID: 17937417
[TBL] [Abstract][Full Text] [Related]
5. Intrabursal injection of clodronate liposomes causes macrophage depletion and inhibits ovulation in the mouse ovary.
Van der Hoek KH; Maddocks S; Woodhouse CM; van Rooijen N; Robertson SA; Norman RJ
Biol Reprod; 2000 Apr; 62(4):1059-66. PubMed ID: 10727278
[TBL] [Abstract][Full Text] [Related]
6. F4/80
Sears SM; Vega AA; Kurlawala Z; Oropilla GB; Krueger A; Shah PP; Doll MA; Miller R; Beverly LJ; Siskind LJ
Kidney360; 2022 May; 3(5):818-833. PubMed ID: 36128491
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro.
Mönkkönen J; Taskinen M; Auriola SO; Urtti A
J Drug Target; 1994; 2(4):299-308. PubMed ID: 7858955
[TBL] [Abstract][Full Text] [Related]
8. Liposomes for specific depletion of macrophages from organs and tissues.
van Rooijen N; Hendrikx E
Methods Mol Biol; 2010; 605():189-203. PubMed ID: 20072882
[TBL] [Abstract][Full Text] [Related]
9. Depletion of systemic macrophages by liposome-encapsulated clodronate attenuates increases in brain quinolinic acid during CNS-localized and systemic immune activation.
Koennecke LA; Zito MA; Proescholdt MG; van Rooijen N; Heyes MP
J Neurochem; 1999 Aug; 73(2):770-9. PubMed ID: 10428075
[TBL] [Abstract][Full Text] [Related]
10. Depletion of systemic macrophages by liposome-encapsulated clodronate attenuates striatal macrophage invasion and neurodegeneration following local endotoxin infusion in gerbils.
Zito MA; Koennecke LA; McAuliffe MJ; McNally B; van Rooijen N; Heyes MP
Brain Res; 2001 Feb; 892(1):13-26. PubMed ID: 11172745
[TBL] [Abstract][Full Text] [Related]
11. Methods for assessing splenic macrophage depletion by liposome encapsulated clodronate.
Camilleri JP; Williams AS; Amos N; Douglas-Jones AG; Love WG; Williams BD
Inflamm Res; 1995 Apr; 44(4):152-7. PubMed ID: 7670932
[TBL] [Abstract][Full Text] [Related]
12. Repeated clodronate-liposome treatment results in neutrophilia and is not effective in limiting obesity-linked metabolic impairments.
Bader JE; Enos RT; Velázquez KT; Carson MS; Sougiannis AT; McGuinness OP; Robinson CM; Murphy EA
Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E358-E372. PubMed ID: 30576244
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-liposome combined with clodronate-liposome inhibits hepatocellular carcinoma through the depletion of macrophages and tumor cells.
Zhang H; Sheng D; Han Z; Zhang L; Sun G; Yang X; Wang X; Wei L; Lu Y; Hou X; Zhang L
Int J Pharm; 2022 Dec; 629():122346. PubMed ID: 36334635
[TBL] [Abstract][Full Text] [Related]
14. The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cells in vitro: the role of calcium and iron.
Mönkkönen J; Heath TD
Calcif Tissue Int; 1993 Aug; 53(2):139-46. PubMed ID: 8402323
[TBL] [Abstract][Full Text] [Related]
15. Liposome mediated depletion of macrophages: an approach for fundamental studies.
Buiting AM; Van Rooijen N
J Drug Target; 1994; 2(5):357-62. PubMed ID: 7704479
[TBL] [Abstract][Full Text] [Related]
16. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis.
Frith JC; Mönkkönen J; Auriola S; Mönkkönen H; Rogers MJ
Arthritis Rheum; 2001 Sep; 44(9):2201-10. PubMed ID: 11592386
[TBL] [Abstract][Full Text] [Related]
17. Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI-CKD transition.
Hu Z; Zhan J; Pei G; Zeng R
Ren Fail; 2023 Dec; 45(1):2149412. PubMed ID: 36636989
[TBL] [Abstract][Full Text] [Related]
18. Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo.
Opperman KS; Vandyke K; Clark KC; Coulter EA; Hewett DR; Mrozik KM; Schwarz N; Evdokiou A; Croucher PI; Psaltis PJ; Noll JE; Zannettino AC
Neoplasia; 2019 Aug; 21(8):777-787. PubMed ID: 31247457
[TBL] [Abstract][Full Text] [Related]
19. Macrophage Depletion Attenuates Acute Renal Damage after Exhaustive Exercise in Mice.
Mizokami T; Shimada M; Suzuki K
Int J Sports Med; 2022 Oct; 43(11):964-970. PubMed ID: 35426091
[TBL] [Abstract][Full Text] [Related]
20. Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid.
Van Rooijen N; Sanders A
Hepatology; 1996 May; 23(5):1239-43. PubMed ID: 8621159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
